M
Madrigal Pharmaceuticals, Inc. (MDGL)
NMS – Real vaqt narxi. Valyuta: USD
510.68
-8.08 (-1.56%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
513.00
+2.32 (0.45%)
Bozordan keyin: Mar 27, 2026, 7:41 PM EDT

NMS – Real vaqt narxi. Valyuta: USD
510.68
-8.08 (-1.56%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
513.00
+2.32 (0.45%)
Bozordan keyin: Mar 27, 2026, 7:41 PM EDT
This stock has a consensus price target of $590.76 based on the ratings of 19 analysts. The high is $964.00 and the low is $360.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 360 | $ 590.76 | $ 964 |
| O’zgarish | -29.51% | 15.68% | 88.77% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-02-20 | 3.59% | B of A Securities | $570 → $529 | Maintains | Neutral |
| 2026-01-28 | 88.77% | Barclays | $964 | Initiates Coverage On | Overweight |
| 2026-01-20 | 45.88% | Citizens | $527 → $745 | Maintains | Market Outperform |
| 2025-12-19 | 76.24% | Piper Sandler | $540 → $900 | Maintains | Overweight |
| 2025-12-11 | 31.2% | B. Riley Securities | $560 → $670 | Maintains | Buy |